563 related articles for article (PubMed ID: 11190029)
1. Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.
Asbell PA
Trans Am Ophthalmol Soc; 2000; 98():285-303. PubMed ID: 11190029
[TBL] [Abstract][Full Text] [Related]
2. Recurrent ocular herpes simplex keratitis following excimer laser photorefractive keratectomy in a rabbit model.
Epstein SP; Fisher EM; Sternberg GJ; Franklin W; Gordon R; Ho JJ; Asbell PA
CLAO J; 2001 Apr; 27(2):94-9. PubMed ID: 11352456
[TBL] [Abstract][Full Text] [Related]
3. Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusis.
Dhaliwal DK; Romanowski EG; Yates KA; Hu D; Mah FS; Fish DN; Gordon YJ
J Cataract Refract Surg; 2001 Aug; 27(8):1288-93. PubMed ID: 11524202
[TBL] [Abstract][Full Text] [Related]
4. Valacyclovir inhibits recovery of ocular HSV-1 after experimental reactivation by excimer laser keratectomy.
Dhaliwal DK; Romanowski EG; Yates KA; Barnhorst DA; Goldstein M; Deeter RG; Fish DN; Gordon YJ
Cornea; 1999 Nov; 18(6):693-9. PubMed ID: 10571301
[TBL] [Abstract][Full Text] [Related]
5. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
[TBL] [Abstract][Full Text] [Related]
6. Efficient reactivation of latent herpes simplex virus type 1 infection by excimer laser keratectomy in the experimental rabbit ocular model.
Dhaliwal DK; Barnhorst DA; Romanowski E; Rehkopf PG; Gordon YJ
Am J Ophthalmol; 1998 Apr; 125(4):488-92. PubMed ID: 9559734
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA
J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396
[TBL] [Abstract][Full Text] [Related]
8. Reactivation of latent herpes simplex virus by excimer laser photokeratectomy.
Pepose JS; Laycock KA; Miller JK; Chansue E; Lenze EJ; Gans LA; Smith ME
Am J Ophthalmol; 1992 Jul; 114(1):45-50. PubMed ID: 1320329
[TBL] [Abstract][Full Text] [Related]
9. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.
Miserocchi E; Modorati G; Galli L; Rama P
Am J Ophthalmol; 2007 Oct; 144(4):547-51. PubMed ID: 17692271
[TBL] [Abstract][Full Text] [Related]
11. Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing.
Beeson WH; Rachel JD
Dermatol Surg; 2002 Apr; 28(4):331-6. PubMed ID: 11966791
[TBL] [Abstract][Full Text] [Related]
12. Excimer laser photokeratectomy reactivates latent herpes simplex virus.
Deai T; Fukuda M; Tomoda Y; Higaki S; Hayashi K; Shimomura Y
Jpn J Ophthalmol; 2004; 48(6):570-2. PubMed ID: 15592782
[TBL] [Abstract][Full Text] [Related]
13. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
[TBL] [Abstract][Full Text] [Related]
14. [Battle with herpes for 37 years].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
[TBL] [Abstract][Full Text] [Related]
15. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
16. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S
Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic perioperative antiviral therapy for LASIK in patients with inactive herpetic keratitis.
de Rojas Silva MV; Díez-Feijóo E; Javaloy J; Sánchez-Salorio M
J Refract Surg; 2006 Apr; 22(4):404-6. PubMed ID: 16629075
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
[TBL] [Abstract][Full Text] [Related]
19. Experimental laser-assisted in situ keratomileusis induces the reactivation of latent herpes simplex virus.
Dhaliwal DK; Romanowski EG; Yates KA; Hu D; Goldstein M; Gordon YJ
Am J Ophthalmol; 2001 Apr; 131(4):506-7. PubMed ID: 11292417
[TBL] [Abstract][Full Text] [Related]
20. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T
Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]